Following the Chinese cFDA’s new policies announced December 1, 2015, expanding opportunities for in-country contract drug manufacturing, PaizaBio and partner Complya Asia have established a formal technical education program in China for producing sterile injectable drugs to Western quality standards following good manufacturing processes (cGMP).   The Trans-Pacific Aseptic Institute of Training (TPA-IT), located in Hangzhou, China, will offer its first class of 50 students March 23-25. The “...